"While there is some skepticism among nurses, I believe that when applied in the right settings, artificial intelligence is far from a threat," says Hadassah Backman, CEO of Guardoc, a clinical data ...

Altera Digital Health embeds Quippe into new AI offering to modernize EHR workflows and convert multimodal provider inputs into structured, codified data "I've seen documentation requirements rise ...

On Tuesday, December 16, at 1 p.m. CT, Fitch & Associates will present the webinar, “Patient charting to improve billing ...

On the market side, the team battled clinician skepticism because many had been burned by AI products that overpromised and ...

Physiologic monitoring devices are so ubiquitous in hospitals that it’s difficult to recall a time without them. The success of integrating this technology into patient care as a regular part of the ...

The ideas and opinions expressed in this Data Supplement do not necessarily reflect those of the American Society of Clinical Oncology (ASCO). The mention of any product, service, or therapy in this ...

SEATTLE--(BUSINESS WIRE)--Saykara is pleased to announce it has received a 2020 Stratus Award in recognition of successfully developing and deploying the first artificially intelligent (AI) voice ...

The Seattle-based startup has been honored for a healthcare product that uses artificial intelligence to reduce the EHR documentation burden. SEATTLE--(BUSINESS WIRE)--Healthcare technology vendor, ...

Forbes contributors publish independent expert analyses and insights. That momentum continues today with the announcement of a $21 million Series A by Layer Health, an ambitious healthcare AI startup ...

In today’s complex healthcare landscape, comprehending your medical chart has become increasingly vital for patient safety and optimal care. Recent studies show that patients who actively engage with ...

Arcellx is a biotech firm developing advanced cell therapies for diseases like cancer, with a focus on their CART-ddBCMA program for multiple myeloma. Recent positive FDA developments have lifted the ...

With the growth in pathway demand, there has been a proliferation of vendors, including OCP programs developed by payers, provider groups, and third parties. This work assesses several national ...